alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                    Exhibit 99.2

                                  CERTIFICATION

         Pursuant to Section 906 of the Corporate Fraud Accountability Act of
2002 (18 U.S.C. Section 1350, as adopted), Stephen A. Levine, Chief Executive
Officer and Chief Financial Officer of Allergy Research Group, Inc. (the
"Company"), hereby certifies that, to the best of their knowledge:

         1. the Annual Report on Form 10-KSB of the Company for the fiscal year
ended December 31, 2002 (the Report) fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or
78o(d)); and

         2. the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: March 28, 2003                       /S/ Stephen A. Levine
                                            ------------------------------------
                                            Stephen A. Levine
                                            CHIEF EXECUTIVE OFFICER AND
                                            CHIEF FINANCIAL OFFICER
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                           1,247
<SECURITIES>                                         0
<RECEIVABLES>                                    1,947
<ALLOWANCES>                                     1,366
<INVENTORY>                                      4,219
<CURRENT-ASSETS>                                 9,373
<PP&E>                                           4,936
<DEPRECIATION>                                     762
<TOTAL-ASSETS>                                  24,217
<CURRENT-LIABILITIES>                            9,369
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          2
<COMMON>                                            55
<OTHER-SE>                                      12,978
<TOTAL-LIABILITY-AND-EQUITY>                    24,217
<SALES>                                          2,661
<TOTAL-REVENUES>                                 2,661
<CGS>                                            1,610
<TOTAL-COSTS>                                    3,753
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                    40
<INTEREST-EXPENSE>                                 136
<INCOME-PRETAX>                                (3,415)
<INCOME-TAX>                                         9
<INCOME-CONTINUING>                            (3,424)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,424)
<EPS-PRIMARY>                                    (.66)
<EPS-DILUTED>                                        0
        

</TABLE>
exh104.htm




EXHIBIT 10.4

















This agreement made as of May 25, 2010







Between







Christine Kan of 33-01, 53 Cairnhill Road, Singapore 229664, Republic of Singapore


(hereinafter called the “creditor”)







And







ALR Technologies, a company duly incorporated under the laws of the state of Nevada and having its registered office at 3350 Riverwood Parkway, Suite 1900, Atlanta, Georgia


(herein called the “borrower” or the “Company”)







Whereas, the creditor has offered the borrower a line of credit.







Now therefore, in consideration previously exchanged, the parties hereto have agreed and do hereby agree as follows:







Borrowing Limit


The Company can borrow up to $1,000,000 from the creditor. The Company will notify the creditor when funds are required.  The creditor may be asked to directly pay amounts on behalf of the Company which would be considered borrowed funds.







Interest Rate


The borrower will charged simple interest at 1% per month on all amounts borrowed.  Amounts only borrowed for a part of the month will be charged interest on a pro-rated basis.







Repayment Terms


The borrowed balance will have not stated terms of repayment, but will be due on demand.  The borrower will provide notice to the Company for any amounts due on demand.  Once demanded, amounts must be repaid within 3 business days.







Security


The amount borrowed is secured by a general security agreement over all the tangible and intangible assets of the borrower.


 


-1-







 


 




 




  





  











  













 


 


 


 


 


Amounts Previously Borrowed


While the terms for this arrangement where being finalized, amounts totaling $92,000 were advanced by the creditor to the borrower.  These were being charged at a simple interest rate of 1% per month.  Now that this operating line of credit has been finalized, these amounts will be transferred under as funds borrowed under the line of credit and will carry the terms as described above.







The parties have executed this Agreement







Signed, sealed and delivered by, Christine Kan,







CHRISTINE KAN


Christine Kan







The corporate seal of ALR Technologies Inc. was affixed in the presence of







SIDNEY CHAN


Sidney Chan


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


- 2 -
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Initial Review Group, Subcommittee A—Cancer Centers.                    

*Date:*                         December 2, 2005.                    

*Time:*                         8 a.m. to 1 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         David E. Maslow, PhD, Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8117, Bethesda, MD 20892-7405, (301) 496-2330,                         *dm65y@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398; Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: August 31, 2005.

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 05-17935 Filed 9-8-05; 8:45 am]

BILLING CODE 4140-01-M
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 97-6253

ELLIS RICHARD DOUGLAS, JR.,

Plaintiff - Appellant,

versus

PRISON HEALTH SERVICES, INCORPORATED; PATRICIA

WRIGHT, M.D., Medical Director, Maryland Penitentiary's Hospital; FAKUNLE, M.D. (Neurologist); MATHUR, M.D.; FLETCHER, D.D.S.; DAVIDSON, D.D.S,

Defendants - Appellees.

Appeal from the United States District Court for the District of

Maryland, at Baltimore. Catherine C. Blake, District Judge. (CA96-325-CCB)

Submitted: May 15, 1997 Decided: June 3, 1997

Before RUSSELL, HALL, and HAMILTON, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Ellis Richard Douglas, Jr., Appellant Pro Se. Joseph Barry Chazen,

Gina Marie Smith, MEYERS, BILLINGSLEY, RODBELL & ROSENBAUM, P.A.,

Riverdale, Maryland; Benjamin Saul Vaughan, ARMSTRONG, DONOHUE &

CEPPOS, CHARTERED, Rockville, Maryland; Christian Andrew Lodowski,

WHARTON, LEVIN, EHRMANTRAUT, KLEIN & NASH, Annapolis, Maryland;

James F. Rosner, Thomas Johns Whiteford, WHITEFORD, TAYLOR &

PRESTON, Towson, Maryland; Roy Leonard Mason, MASON, KETTERMAN &

MORGAN, Baltimore, Maryland; Deborah Maude Peyton, MASON, KETTERMAN

& MORGAN, Hunt Valley, Maryland, for Appellees.
2
3

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).

PER CURIAM:

Appellant appeals the district court's order denying relief on

his 42 U.S.C. § 1983 (1994) complaint. We have reviewed the record

and the district court's opinion and find no reversible error.

Accordingly, we affirm on the reasoning of the district court.

Douglas v. Prison Health Serv., Inc., No. CA-96-325-CCB (D. Md.

Feb. 7, 1997). We dispense with oral argument because the facts and

legal contentions are adequately presented in the materials before

the court and argument would not aid the decisional process.

AFFIRMED
# Commission Regulation (EU) No 589/2014 (repealed)Show full title

Commission Regulation (EU) No 589/2014 of 2 June 2014 laying down methods of sampling and analysis for the control of levels            of dioxins, dioxin-like PCBs and non-dioxin-like PCBs in certain foodstuffs and repealing Regulation (EU) No 252/2012 (Text            with EEA relevance) (repealed)         

        - Previous
        - Next

U.K.

# Commission Regulation (EU) No 589/2014                     

# of 2 June 2014

# laying down methods of sampling and analysis for the control of levels of dioxins, dioxin-like PCBs and non-dioxin-like PCBs                        in certain foodstuffs and repealing Regulation (EU) No 252/2012                     

# (Text with EEA relevance) (repealed)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .                        

Textual Amendments

F1Repealed by Commission Regulation (EU) 2017/644 of 5 April 2017 laying down methods of sampling and analysis for the control of levels                                 of dioxins, dioxin-like PCBs and non-dioxin-like PCBs in certain foodstuffs and repealing Regulation (EU) No 589/2014 (Text                                 with EEA relevance. ).
# C_2023112EN.01004801.xml

| 27.3.2023 | EN | Official Journal of the European Union | C 112/48 |
| --- | --- | --- | --- |

27.3.2023

EN

Official Journal of the European Union

C 112/48

---

Action brought on 13 February 2023 — Aesculap v EUIPO — Aeneas (AESKUCARE)

(Case T-65/23)

(2023/C 112/62)

Language in which the application was lodged: German

Parties

Applicant: Aesculap AG (Tuttlingen, Germany) (represented by: N. Hebeis, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Aeneas GmbH & Co. KG (Wendelsheim, Germany)

Details of the proceedings before EUIPO

Applicant for the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: Application for the EU word mark ‘AESKUCARE’ — Application No 17 789 025

Proceedings before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 12 November 2022 in Case R 18/2022-2

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision in so far as it annulled the decision of the Opposition Division of EUIPO of 30 November 2021 and rejected the opposition in respect of the claimed goods and services in Classes 5, 42 and 44; |
| --- | --- |

—

annul the contested decision in so far as it annulled the decision of the Opposition Division of EUIPO of 30 November 2021 and rejected the opposition in respect of the claimed goods and services in Classes 5, 42 and 44;

| — | order EUIPO to pay the costs of the proceedings before the General Court and order the intervener to pay the costs of the proceedings before EUIPO. |
| --- | --- |

—

order EUIPO to pay the costs of the proceedings before the General Court and order the intervener to pay the costs of the proceedings before EUIPO.

Plea in law

| — | Infringement of Article 8(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |
| --- | --- |

—

Infringement of Article 8(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

---
<PAGE>

                                                                    EXHIBIT 32.1

CERTIFICATION

            Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
                    (Subsections (a) and (b) of Section 1350,
                   Chapter 63 of Title 18, United States Code)

         Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections
(a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the
undersigned officer of Western Wireless Corporation, a Washington corporation
(the "Company"), does hereby certify, to such officer's knowledge, that:

         The Quarterly Report on Form 10-Q for the quarter ended September 30,
         2003 (the "Form 10-Q") of the Company fully complies with the
         requirements of Section 13(a) or 15(d) of the Securities Exchange Act
         of 1934 and information contained in the Form 10-Q fairly presents, in
         all material respects, the financial condition and results of
         operations of the Company.

Dated: November 7, 2003

                                               By: /s/ JOHN W. STANTON
                                                   -----------------------------
                                                   John W. Stanton
                                                   Chairman and Chief
                                                   Executive Officer

         The foregoing certification is being furnished solely pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of
Section 1350, Chapter 63 of Title 18, United States Code).
IN RE M.B.M.

No. COA07-378.

Court of Appeals of North Carolina.

Filed November 20, 2007.

Certification Date December 10, 2007.

Appeal from Wake (03JB56).

Cases reported without published opinion. Affirmed.
##### 



EXHIBIT 10.99

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Gene Logic Inc. (the Company) on
Form 10-K for the year ending December 31, 2002, as filed with the Securities
and Exchange Commission on the date hereof (the Report), each of Mark D.
Gessler, the Chief Executive Officer of the Company, and Philip L. Rohrer, Jr.,
the Chief Financial Officer of the Company, hereby certify, pursuant to and for
purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to his knowledge:



|                                                                                                                                                       
|-------------------------------------------------------------------------------------------------------------------------------------------------------
|(1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and                              
|                                                                                                                                                       
|(2) The information contained in the Report fairly
presents, in all material respects, the financial
condition and results of operations of the Company

|    |  |                         |  |     |  |                          
|--- |  | ----------------------- |  | --- |  | -------------------------
|By: |  | /s/ Mark D. Gessler     |  | By: |  | /s/ Philip L. Rohrer, Jr.
|    |  |                         |  |     |  |                          
|    |  | Mark D. Gessler         |  |     |  | Philip L. Rohrer, Jr.    
|    |  | Chief Executive Officer |  |     |  | Chief Financial Officer  
|    |  | March 19, 2003          |  |     |  | March 19, 2003
STATE of North Carolina v. Onzora Fitzgerald JOHNSON and Jerry Wayne Whisonant, Jr.

No. 269P04-2.

Supreme Court of North Carolina.

August 23, 2007.

Onzora Johnson, pro se.

*370James M. Stanley, Jr., Elizabeth N. Strickland, Assistant Attorney Generals, William D. Kenerly, District Attorney, for State of NC.

*ORDER*

Upon consideration of the petition filed by Defendant on the 13th day of February 2007 in this matter for a writ of certiorari to review the order of the North Carolina Court of Appeals, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

"Dismissed by order of the Court in conference, this the 23rd day of August 2007."
STATE v. OLIVER.

No. COA07-972.

Court of Appeals of North Carolina.

Filed August 19, 2008.

Certification Date September 8, 2008.

Appeal from Mecklenburg (06CRS223144, 06CRS223145, 06CRS223146).

Case reported without published opinion. No error.
[Federal Register Volume 70, Number 170 (Friday, September 2, 2005)]
[Notices]
[Page 52440]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-17506]


-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[AZ-411-1232-FH]


Floating Permit To Change at Gila Box Riparian National 
Conservation Area

AGENCY: Bureau of Land Management, Interior.

ACTION: Change the permit required for floating the Gila River from a 
Recreation Use Permit to a Special Recreation Permit.

-----------------------------------------------------------------------

SUMMARY: The Federal Lands Recreation Enhancement Act (FLREA) requires 
that the Bureau of Land Management (BLM) change its fee collection at 
the Gila Box Riparian National Conservation Area (RNCA) from Recreation 
Use Permits to Special Recreation Permits. This change will only affect 
the Gila River floatboat put-in facility along the Gila River. The fee 
remains the same.

DATES: This change becomes effective immediately upon termination of 
the required 30-day public notification process following publication 
of this Notice.

FOR FURTHER INFORMATION CONTACT: Jeff Wilbanks, BLM Safford Field 
Office, 711 14th Avenue, Safford, AZ 85546; call (928) 348-4573; or e-
mail <a href="/cdn-cgi/l/email-protection#1a507f7c7c454d7376787b7471695a787677347d756c"><span class="__cf_email__" data-cfemail="fab09f9c9ca5ad9396989b949189ba989697d49d958c">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Congress passed the FLREA in 2004 as Public 
Law 108-447.

    Dated: July 7, 2005.
Bonnie Winslow,
Acting Field Manager.
[FR Doc. 05-17506 Filed 9-1-05; 8:45 am]
BILLING CODE 4310-32-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
STATE of North Carolina v. Timothy Cornell McDONALD.

No. 410P08.

Supreme Court of North Carolina.

December 11, 2008.

Ann B. Petersen, Chapel Hill, for McDonald.

Kip Sturgis, Assistant Attorney General, David Saacks, District Attorney, for State of NC.

Prior report: ___ N.C.App. ___, 663 S.E.2d 462.

*ORDER*

Upon consideration of the petition filed on the 9th day of September 2008 by Defendant in this matter for discretionary review of the decision of the North Carolina Court of Appeals pursuant to G.S. 7A-31, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

"Denied by order of the Court in conference, this the 11th day of December 2008."
STATE v. Darrell Wayne MANESS.

No. 402A06.

Supreme Court of North Carolina.

June 3, 2008.

M. Gordon Widenhouse, Jr., Chapel Hill, Katherine Jane Allen, Assistant Appellate Defender, for Maness.

Wlliam B. Crumpler, Assistant Attorney General, Rex Gore, District, Attorney, for State of NC.

The following order has been entered on the motion filed on the 30th day of May 2008 by State of NC for Extension of Time to File Brief:

"Motion Allowed. State of NC shall have up to and including the 9th day of July 2008 to file and serve his/her brief with this Court. By order of the Court in conference this the 3rd day of June 2008."